| - GRCh37:
- ChrMT:4332
- GRCh38:
- ChrMT:4332
| MT-TQ | | Mitochondrial disease | Uncertain significance (Jan 23, 2023) | reviewed by expert panel FDA Recognized Database |
| - GRCh37:
- ChrMT:4335
- GRCh38:
- ChrMT:4335
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4336
- GRCh38:
- ChrMT:4336
| MT-TQ | | not specified, not provided, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke
| Conflicting interpretations of pathogenicity (Aug 17, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrMT:4339
- GRCh38:
- ChrMT:4339
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4340
- GRCh38:
- ChrMT:4340
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4343
- GRCh38:
- ChrMT:4343
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4350
- GRCh38:
- ChrMT:4350
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4353
- GRCh38:
- ChrMT:4353
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4360
- GRCh38:
- ChrMT:4360
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4363
- GRCh38:
- ChrMT:4363
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4365-4366
- GRCh38:
- ChrMT:4365-4366
| MT-TQ | | Myopathy | Pathogenic (Oct 1, 2000) | no assertion criteria provided |
| - GRCh37:
- ChrMT:4370
- GRCh38:
- ChrMT:4370
| MT-TQ | | not provided, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- ChrMT:4371
- GRCh38:
- ChrMT:4371
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4372
- GRCh38:
- ChrMT:4372
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely pathogenic (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4373
- GRCh38:
- ChrMT:4373
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4375
- GRCh38:
- ChrMT:4375
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4381
- GRCh38:
- ChrMT:4381
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4384
- GRCh38:
- ChrMT:4384
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4384
- GRCh38:
- ChrMT:4384
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4385
- GRCh38:
- ChrMT:4385
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4385
- GRCh38:
- ChrMT:4385
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4386
- GRCh38:
- ChrMT:4386
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4387
- GRCh38:
- ChrMT:4387
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Likely benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4388
- GRCh38:
- ChrMT:4388
| MT-TQ | | not provided, Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Conflicting interpretations of pathogenicity (Jul 12, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- ChrMT:4394
- GRCh38:
- ChrMT:4394
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4395
- GRCh38:
- ChrMT:4395
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Benign (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4399
- GRCh38:
- ChrMT:4399
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- ChrMT:4400
- GRCh38:
- ChrMT:4400
| MT-TQ | | Juvenile myopathy, encephalopathy, lactic acidosis AND stroke | Uncertain significance (Jul 12, 2019) | criteria provided, single submitter |